Invention Grant
- Patent Title: Anti-PD-1 antibodies
-
Application No.: US16352194Application Date: 2019-03-13
-
Publication No.: US11028173B2Publication Date: 2021-06-08
- Inventor: Weidong Jiang , Pei-Hua Lin , Chi-Ling Tseng
- Applicant: Shanghai Henlius Biotech Inc.
- Applicant Address: CN Shanghai
- Assignee: Shanghai Henlius Biotech Inc.
- Current Assignee: Shanghai Henlius Biotech Inc.
- Current Assignee Address: CN Shanghai
- Agency: Thomas Horstemeyer, LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; A61K51/10 ; A61K47/68 ; A61P35/00 ; C07K16/22 ; G01N33/574 ; A61K49/00

Abstract:
Provided are anti-PD-1 antibodies, and antigen binding fragments thereof. Also provided are isolated nucleic acid molecules that encode the anti-PD-1 antibodies or antigen binding fragments thereof, related expression vectors, and host cells. Provided are methods of making anti-PD-1 antibodies, and antigen binding fragments thereof. Also provided are related pharmaceutical compositions and methods of their use to treat subjects. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Public/Granted literature
- US20190218295A1 ANTI-PD-1 ANTIBODIES Public/Granted day:2019-07-18
Information query